IOL Chemicals and Pharmaceuticals Limited

rs,

stries like pharmaceuticals, ink industry, flexible packaging, adhesives, surface coatings, flavours, paints & lamination and essences etc. Captive co-generation unit with capacity of 17 MW to meet pow

17 MW

tings, flavours, paints & lamination and essences etc. Captive co-generation unit with capacity of 17 MW to meet power and steam requirements To be amongst the most admired companies in APIs, Intermedia

30%

ation Iso Butyl Benzene (IBB) commercialised with 8 company worldwide being in India with ~30% Global share products in pipeline backward integrated with ~35% Global share Debt free company

35%

rldwide being in India with ~30% Global share products in pipeline backward integrated with ~35% Global share Debt free company, Spread over a sprawling Zero Discharge Effluent Customer base

rs. 5

umar Rana (Director – Works) after quality assurance, quality control & corporate regulatory affairs. 5 Experienced Independent Directors Rajender Mohan Malla (Chairman and Independent Director) Dr. Sa

4MW

ement of Acetic Anhydride Plant 1999 Unit-01 Ibuprofen (Dedicated) Co-Generation Plant – 4MW 2000 Commencement of Ibuprofen Unit-1 2007 Listing on NSE Co-Generation Plant – 13MW 2010

13MW

lant – 4MW 2000 Commencement of Ibuprofen Unit-1 2007 Listing on NSE Co-Generation Plant – 13MW 2010 2009 Commencement of IBB, MCA and Acetyl Chloride Plants *Unit-10 was commercialized i

17%

ate Textiles Ink Paints Pesticides 12 Product wise Segmentation – Quarterly Q3FY22 555 96 (17%) 160 (29%) 299 (54%) Q2FY22 538 81 (15%) 157 (29%) 299 (56%) Q3FY21 513 60 (12%) 209 (41

29%

es Ink Paints Pesticides 12 Product wise Segmentation – Quarterly Q3FY22 555 96 (17%) 160 (29%) 299 (54%) Q2FY22 538 81 (15%) 157 (29%) 299 (56%) Q3FY21 513 60 (12%) 209 (41%) 243 (47

54%

ints Pesticides 12 Product wise Segmentation – Quarterly Q3FY22 555 96 (17%) 160 (29%) 299 (54%) Q2FY22 538 81 (15%) 157 (29%) 299 (56%) Q3FY21 513 60 (12%) 209 (41%) 243 (47%) Chemica

15%

roduct wise Segmentation – Quarterly Q3FY22 555 96 (17%) 160 (29%) 299 (54%) Q2FY22 538 81 (15%) 157 (29%) 299 (56%) Q3FY21 513 60 (12%) 209 (41%) 243 (47%) Chemicals Ibuprofen Other AP

56%

on – Quarterly Q3FY22 555 96 (17%) 160 (29%) 299 (54%) Q2FY22 538 81 (15%) 157 (29%) 299 (56%) Q3FY21 513 60 (12%) 209 (41%) 243 (47%) Chemicals Ibuprofen Other API’s All figures in IN

For further details

1